Efficacy and safety of olorinab
CenExel is proud to announce the publication of the work of Brett English, PharmD, PhD, from CenExel's Clinical Sciences team, in the Neurogastroenterology & Mortility journal. Dr. English participated
View More Emraclidine for the treatment of schizophrenia
CenExel is proud to announce that the work of David Walling, PhD, CEO and Principal Investigator at CenExel CNS, joined lead author, John H Krystal, as co-author of the
View More Validation of a suite of ERP and QEEG biomarkers
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry led-study in subjects with schizophrenia and healthy volunteers.
View More Placebo-Control Reminder Script
General medicine studies are not immune to the placebo effect, where 30-40% of patients report improved subjective and objective outcomes in general medical studies (Hrobjartsson & Gotzsche, 2001). The high
View More
Efficacy and safety of naproxen sodium in acute postsurgical dental pain
Analgesic efficacy and safety of naproxen sodium versus hydrocodone / acetaminophen in acute postsurgical dental pain: a randomized, double-blind, placebo-controlled trial Stephen A. Cooper (1), Paul J. Desjardins (2),
View More
